Trials / Conditions / Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
6 registered clinical trials studyying Transthyretin Amyloid Cardiomyopathy (ATTR CM) — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Study to Learn About the Use of Acoramidis in Patients With a Heart Condition Called Transthyretin Amyloid C NCT07235462 | Bayer | — |
| Recruiting | CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-000 NCT07207811 | Novo Nordisk A/S | Phase 3 |
| Recruiting | Thailand ATTR-CM Registry NCT06338696 | Mahidol University | — |
| Active Not Recruiting | A Research Study to Look at Long-term Treatment With a Medicine Called NNC6019-0001 for People Who Have Heart NCT06260709 | Novo Nordisk A/S | Phase 2 |
| Completed | A Research Study to Look at How a New Medicine Called NNC6019-0001 Works and How Safe it is for People Who Hav NCT05442047 | Novo Nordisk A/S | Phase 2 |
| Unknown | A Prospective Study to Assess the Utility of CA-4F in a Canadian Cardiology Setting NCT05210010 | Ensho Health Intelligent Systems Inc. | N/A |